discovery begins with - agilent...to acquire dako, a cancer diagnostics company in denmark...

14
D ISCOVERY B EGINS WITH A GILENT T ECHNOLOGIES T HE INDUSTRY LEADING AND MOST COMPREHENSIVE ANALYTICAL PORTFOLIO 1

Upload: others

Post on 10-Apr-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

D I S C O V E R Y B E G I N S W I T H

A G I L E N T T E C H N O L O G I E S

T H E I N D U S T R Y L E A D I N G A N D M O S T

C O M P R E H E N S I V E A N A L Y T I C A L

P O R T F O L I O

1

Page 2: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

3

A G I L E N T AT A G L A N C E

REVENUE IN FY11 $6.6 billion (more than 70% generated outside the U.S.)

EMPLOYEES 20,000

PRESIDENT AND CEO William P. (Bill) Sullivan

CUSTOMER LOCATIONS 100+ countries

MANUFACTURING AND

R&D LOCATIONS U.S., Europe, Asia Pacific

NYSE A

Page 3: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

4

A G I L E N T AT A G L A N C E

• Wireless technologies

• Mobile phone R&D and manufacturing

• Aerospace/defense systems and maintenance

• Computer & industrial research & manufacturing

• Food safety, quality

• Energy research, production

• Quality of air, water, soil

• Forensics, drugs of abuse

• Pharmaceutical research and manufacturing

• Academic and government research

• Cancer diagnostics

• Cytogenetics research

• Genomics tools for molecular analysis

Electronic Measurement Group

Chemical Analysis Group

Life Sciences Group

Diagnostics and Genomics Group

Addressing critical measurement challenges

Page 4: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

8

M AY 1 4 , 2 0 1 0 : A G I L E N T A C Q U I R E S VA R I A N I N C .

• New technologies, more applications,

expanded markets

• Ability to provide more complete solutions

to our life science and chemical analysis

customers

• Opportunity to become LSCA market

leader, building on our undisputed

leadership in electronic measurement

• Opportunity to leverage our electronic and

bio-analytical measurement capability

across our expanded product portfolio

What Agilent gains:

Combining the power of two

Silicon Valley pioneers

Page 5: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

9

“The acquisition will establish Agilent as a clear market leader

in analytical solutions and give us the talent and technology base

for creating unique new products and markets.”

- Bill Sullivan, President and CEO, Agilent Technologies

A H E R I TA G E O F I N N OVAT I O N : VA R I A N & A G I L E N T

Page 6: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

10

• Agilent has signed a definitive agreement with EQT

to acquire Dako, a cancer diagnostics company in

Denmark

• All-cash deal of $2.2 billion

• Largest in Agilent’s history

• Expected to be finalized within 60 days

• Dako will operate as an independent business

within Agilent

• Reports to Agilent CEO

• No changes to management structure, payroll,

facilities

• Dako keeps name, adds Agilent tagline

A G I L E N T TO A C Q U I R E D A KO

Page 7: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

X-Ray

B I O A N A LY T I C A L P L AT F O R M S A N D M A R K E T S

16

DNA Arrays

TOF /MS

GC/MS CE

ICP/MS

QPCR

Array Scanner Atomic Force Microscopy

QTOF MS/MS

QQQ MS/MS

Chip HPLC/MS

HPLC

Molecular labeling Technology

Q-PCR Reagents

Lab Automation

PCR-RFLP

BioAnalyzer

Genomics

Proteomics

Metabolomics

Pharma R&D/QC

Environmental

Chemical

Energy

Food

NMR

Page 8: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

Isidro Masana

Especialista Productos LC-CE-GC/MS

Agilent Technologies

División de Biociencia y Análisis Químico

Page 9: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

Razones y Aportaciones

de la Biología Integrada

• Extrema complejidad y variabilidad de los procesos biológicos.

• La inhibición de una ruta metabólica es habitual que genere la activación de

otras vías alternativas.

• Mutaciones, defectos en la transcripción, modificaciones

postraduccionales,…..

• La Integración de datos experimentales de las diferentes

–ómicas permitirá validar los resultados experimentales a través de

una coherente interpretación biológica de los cambios de expresión

observados entre distintas las distintas poblaciones de individuos/

tratamientos/ enfermedades/…. comparadas en el estudio.

Página 18

Page 10: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

Modern -omics technologies yield “snapshots” of discrete parts of the biological process. The value of looking only at results from individual disciplines is limited.

• The real biological story is in the relationships amongst the biological entities, rather

than the entities themselves.

• Interpretive value comes from integrating diverse measurements within their biological

context.

Multi-omics Analysis

Page 11: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

Agilent Technologies - una Compañía con una Fuerte

Inversión en España: +500 empleados en España

WIN 2010 organization

Agilent Restricted

July 7th to 9th , 2010

Page 21

“International Agilent Bussiness

Center”

World Trade Center

Barcelona

Oficinas/Fábrica en: Barcelona, Málaga, Madrid, Bilbao.

Page 12: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

Agenda

Page 22

Miguel Viribay Sales Director Iberia LSG.

Page 13: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

Page 23

Jaume Morales

Page 14: DISCOVERY BEGINS WITH - Agilent...to acquire Dako, a cancer diagnostics company in Denmark •All-cash deal of $2.2 billion •Largest in Agilent’s history •Expected to be finalized

D I S C O V E R Y B E G I N S W I T H

A G I L E N T T E C H N O L O G I E S

T H E I N D U S T R Y L E A D I N G A N D M O S T

C O M P R E H E N S I V E A N A L Y T I C A L

P O R T F O L I O

24